These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12499639)

  • 41. Vielanin P enhances the cytotoxicity of doxorubicin via the inhibition of PI3K/Nrf2-stimulated MRP1 expression in MCF-7 and K562 DOX-resistant cell lines.
    Gao HL; Xia YZ; Zhang YL; Yang L; Kong LY
    Phytomedicine; 2019 May; 58():152885. PubMed ID: 31009836
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CIAPIN1 confers multidrug resistance by upregulating the expression of MDR-1 and MRP-1 in gastric cancer cells.
    Hao Z; Li X; Qiao T; Du R; Hong L; Fan D
    Cancer Biol Ther; 2006 Mar; 5(3):261-6. PubMed ID: 16410721
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reversal of multidrug resistance by 7-O-benzoylpyripyropene A in multidrug-resistant tumor cells.
    Rho MC; Hayashi M; Fukami A; Obata R; Sunazuka T; Tomoda H; Komiyama K; Omura S
    J Antibiot (Tokyo); 2000 Oct; 53(10):1201-6. PubMed ID: 11132967
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway.
    Chen T; Wang C; Liu Q; Meng Q; Sun H; Huo X; Sun P; Peng J; Liu Z; Yang X; Liu K
    Cancer Biol Ther; 2015; 16(1):106-14. PubMed ID: 25482933
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular mechanism study of chemosensitization of doxorubicin-resistant human myelogenous leukemia cells induced by a composite polymer micelle.
    Han M; Diao YY; Jiang HL; Ying XY; Chen DW; Liang WQ; Gao JQ
    Int J Pharm; 2011 Nov; 420(2):404-11. PubMed ID: 21945184
    [TBL] [Abstract][Full Text] [Related]  

  • 46. YAN, a novel microtubule inhibitor, inhibits P-gp and MRP1 function and induces mitotic slippage followed by apoptosis in multidrug-resistant A549/Taxol cells.
    Gao M; Liu T; Li J; Guan Q; Wang H; Yan S; Li Z; Zuo D; Zhang W; Wu Y
    Toxicol In Vitro; 2020 Dec; 69():104971. PubMed ID: 32805372
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regulation of cellular glutathione modulates nuclear accumulation of daunorubicin in human MCF7 cells overexpressing multidrug resistance associated protein.
    Benderra Z; Trussardi A; Morjani H; Villa AM; Doglia SM; Manfait M
    Eur J Cancer; 2000 Feb; 36(3):428-34. PubMed ID: 10708946
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Modulation of human small cell lung cancer cell line GLC4/ADR multidrug resistance in the inhibition of multidrug resistance-associated protein and its antisense].
    Peng X; Feng F; Zhang W
    Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):355-8. PubMed ID: 11810759
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The drug resistance proteins, multidrug resistance-associated protein and P-glycoprotein, do not confer resistance to Fas-induced cell death.
    Cullen K; Davey R; Davey M
    Cytometry; 2001 Mar; 43(3):189-94. PubMed ID: 11170105
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 5-Oxo-hexahydroquinoline derivatives as modulators of P-gp, MRP1 and BCRP transporters to overcome multidrug resistance in cancer cells.
    Ranjbar S; Khonkarn R; Moreno A; Baubichon-Cortay H; Miri R; Khoshneviszadeh M; Saso L; Edraki N; Falson P; Firuzi O
    Toxicol Appl Pharmacol; 2019 Jan; 362():136-149. PubMed ID: 30391378
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of human cancer cell line growth and human umbilical vein endothelial cell angiogenesis by artemisinin derivatives in vitro.
    Chen HH; Zhou HJ; Fang X
    Pharmacol Res; 2003 Sep; 48(3):231-6. PubMed ID: 12860439
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin.
    Kim TH; Shin YJ; Won AJ; Lee BM; Choi WS; Jung JH; Chung HY; Kim HS
    Biochim Biophys Acta; 2014 Jan; 1840(1):615-25. PubMed ID: 24161697
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of the P-glycoprotein- and multidrug resistance protein-mediated efflux of anthracyclines and calceinacetoxymethyl ester by PAK-104P.
    Marbeuf-Gueye C; Salerno M; Quidu P; Garnier-Suillerot A
    Eur J Pharmacol; 2000 Mar; 391(3):207-16. PubMed ID: 10729360
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evidence for functional discrimination between leukemic cells overexpressing multidrug-resistance associated protein and P-glycoprotein.
    Benderra Z; Morjani H; Trussardi A; Manfait M
    Adv Exp Med Biol; 1999; 457():151-60. PubMed ID: 10500790
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Olmutinib Reverses Doxorubicin Resistance in ETS1-Overexpressing Leukemia Cells.
    Zhong J; Zhang J; Yu X; Zhang X; Dian L
    Med Sci Monit; 2020 Aug; 26():e924922. PubMed ID: 32830792
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Overexpression of the ABC transporter TAP in multidrug-resistant human cancer cell lines.
    Izquierdo MA; Neefjes JJ; Mathari AE; Flens MJ; Scheffer GL; Scheper RJ
    Br J Cancer; 1996 Dec; 74(12):1961-7. PubMed ID: 8980397
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of H+-ATPase-dependent activity of multidrug resistance-associated protein in homoharringtonine-resistant human leukemic K562 cells.
    Benderra Z; Morjani H; Trussardi A; Manfait M
    Leukemia; 1998 Oct; 12(10):1539-44. PubMed ID: 9766497
    [TBL] [Abstract][Full Text] [Related]  

  • 58. ATP- and glutathione-dependent transport of chemotherapeutic drugs by the multidrug resistance protein MRP1.
    Renes J; de Vries EG; Nienhuis EF; Jansen PL; Müller M
    Br J Pharmacol; 1999 Feb; 126(3):681-8. PubMed ID: 10188979
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Function and expression of ATP-binding cassette transporters in cultured human Y79 retinoblastoma cells.
    Ishikawa Y; Nagai J; Okada Y; Sato K; Yumoto R; Takano M
    Biol Pharm Bull; 2010; 33(3):504-11. PubMed ID: 20190417
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pyrrolopyrimidine derivatives and purine analogs as novel activators of Multidrug Resistance-associated Protein 1 (MRP1, ABCC1).
    Schmitt SM; Stefan K; Wiese M
    Biochim Biophys Acta Biomembr; 2017 Jan; 1859(1):69-79. PubMed ID: 27810353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.